Impact of thyroid disorders on the incidence of non‐alcoholic fatty liver disease in Germany-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Impact of thyroid disorders on the incidence of non‐alcoholic fatty liver disease in Germany

Published:2021-07-20 Issue:7 Volume:9 Page:829-836
ISSN:2050-6406
Container-title:United European Gastroenterology Journal
language:en
Short-container-title:United European Gastroenterol. j.

Author:

Labenz Christian¹²³,Kostev Karel⁴,Armandi Angelo¹³⁵,Galle Peter R.¹²,Schattenberg Jörn M.¹²³^ORCID

Affiliation:

1. Department of Internal Medicine I University Medical Center of the Johannes Gutenberg‐University Mainz Germany

2. Cirrhosis Center Mainz (CCM) University Medical Center of the Johannes Gutenberg‐University Mainz Germany

3. Metabolic Liver Research Program University Medical Center of the Johannes Gutenberg‐University Mainz Germany

4. Epidemiology IQVIA Frankfurt am Main Germany

5. Department of Medical Sciences Division of Gastroenterology University of Torino Torino Italy

Publisher

Wiley

Subject

Gastroenterology,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ueg2.12124

Reference31 articles.

1. Disease burden and economic impact of diagnosed non‐alcoholic steatohepatitis in five European countries in 2018: A cost‐of‐illness analysis

2. NAFLD — sounding the alarm on a silent epidemic

3. Nonalcoholic steatohepatitis

4. Refining Noninvasive Diagnostics In Nonalcoholic Fatty Liver Disease: Closing the Gap to Detect Advanced Fibrosis

5. Multicenter Validation Study of a Diagnostic Algorithm to Detect NASH and Fibrosis in NAFLD Patients With Low NAFLD Fibrosis Score or Liver Stiffness

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association between primary hypothyroidism and metabolic dysfunction-associated steatotic liver disease: an updated meta-analysis;Gut;2024-05-23

2. Intrahepatic hypothyroidism in MASLD: Role of liver-specific thyromimetics including resmetirom;Diabetes & Metabolic Syndrome: Clinical Research & Reviews;2024-05

3. Resmetirom, the first approved drug for the management of metabolic dysfunction-associated steatohepatitis: Trials, opportunities, and challenges;Metabolism;2024-05

4. Global epidemiology of type 2 diabetes in patients with NAFLD or MAFLD: a systematic review and meta-analysis;BMC Medicine;2024-03-06

5. Endocrine aspects of metabolic dysfunction-associated steatotic liver disease (MASLD): Beyond insulin resistance;Journal of Hepatology;2023-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3